Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Singular Genomics Systems, Inc. - Common Stock (NQ: OMIC )

19.77 -0.12 (-0.58%)
Streaming Delayed Price Updated: 11:06 AM EST, Jan 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,859
Open 19.80
Bid (Size) 19.70 (9)
Ask (Size) 19.85 (1)
Prev. Close 19.89
Today's Range 19.71 - 19.85
52wk Range 5.340 - 23.41
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OMIC, AMCR, ZUO on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SINGULAR GENOMICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Singular Genomics Systems, Inc. - OMIC
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
+0.89%
+0.89%
1 Month
+2.67%
+2.67%
3 Month
+49.36%
+49.36%
6 Month
+135.70%
+135.70%
1 Year
+62.72%
+62.72%

More News

Read More
OMIC Investors Have the Opportunity to Join Investigation of Singular Genomics Systems, Inc. with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
OMIC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Singular Genomics Systems, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates OMIC, MRNS, VCSA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SINGULAR GENOMICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Singular Genomics Systems, Inc. - OMIC
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, OMIC, NEUE, VINC on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, OMIC, LTRPA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Singular Genomics Systems, Inc. (Nasdaq - OMIC), Nordstrom, Inc. (NYSE - JWN), Despegar.com, Corp. (NYSE - DESP), Patterson Companies, Inc. (Nasdaq - PDCO)
From Brodsky & Smith LLC
Via GlobeNewswire
OMIC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Singular Genomics Systems, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Shareholder Alert: Ademi LLP Investigates Whether Singular Genomics Systems, Inc. is Obtaining a Fair Price for Its Public Shareholders
From Ademi LLP
Via Business Wire
Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
From Singular Genomics Systems, Inc.
Via GlobeNewswire
$1.8M Bet On Singular Genomics? Check Out These 3 Stocks Executives Are Buying
Via Benzinga
Dow Jumps 400 Points; Adobe Shares Plummet After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
What's Going On With Singular Genomics Stock Friday?
Via Benzinga
Singular Genomics Receives Non-Binding Acquisition Proposal from Deerfield
From Singular Genomics Systems, Inc.
Via GlobeNewswire
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Singular Genomics Reports Recent Highlights and Second Quarter 2024 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.